EGFR Positive Non-small Cell Lung Cancer
Showing NaN - NaN of 1
Stage IV NSCLC, Targeted Therapy, Nonsmall Cell Lung Cancer Trial in Boston (POISE)
Not yet recruiting
- Stage IV Non-small Cell Lung Cancer
- +7 more
- POISE
-
Boston, MassachusettsMassachusetts General Hospital
Apr 13, 2022